{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:28:57Z","timestamp":1778858937752,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81960525"],"award-info":[{"award-number":["81960525"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160591"],"award-info":[{"award-number":["82160591"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Most Hepatocellular carcinoma (HCC) patients are in advanced or metastatic stage at the time of diagnosis. Prognosis for advanced HCC patients is dismal. This study was based on our previous microarray results, and aimed to explore the promising diagnostic and prognostic markers for advanced HCC by focusing on the important function of KLF2.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The Cancer Genome Atlas (TCGA), Cancer Genome Consortium database (ICGC), and the Gene Expression Comprehensive Database (GEO) provided the raw data of this study research. The cBioPortal platform, CeDR Atlas platform, and the Human Protein Atlas (HPA) website were applied to analyze the mutational landscape and single-cell sequencing data of KLF2. Basing on the results of single-cell sequencing analyses, we further explored the molecular mechanism of KLF2 regulation in the fibrosis and immune infiltration of HCC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Decreased KLF2 expression was discovered to be mainly regulated by hypermethylation, and indicated a poor prognosis of HCC. Single-cell level expression analyses revealed KLF2 was highly expressed in immune cells and fibroblasts. The function enrichment analysis of KLF2 targets indicated the crucial association between KLF2 and tumor matrix. 33-genes related with cancer associated fibroblasts (CAFs) were collected to identify the significant association of KLF2 with fibrosis. And SPP1 was validated as a promising prognostic and diagnostic marker for advanced HCC patients. CXCR6 CD8<jats:sup>+<\/jats:sup> T cells were noted as a predominant proportion in the immune microenvironment, and T cell receptor CD3D was discovered to be a potential therapeutic biomarker for HCC immunotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study identified that KLF2 is an important factor promoting HCC progression by affecting the fibrosis and immune infiltration, highlighting its great potential as a novel prognostic biomarker for advanced HCC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12859-023-05391-0","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T10:02:09Z","timestamp":1688032929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comprehensive analysis of KLF2 as a prognostic biomarker associated with fibrosis and immune infiltration in advanced hepatocellular carcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Xue-Qin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuo-Lin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"issue":"3","key":"5391_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"5391_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3892\/mco.2014.259","volume":"2","author":"H Aino","year":"2014","unstructured":"Aino H, Sumie S, Niizeki T, Kuromatsu R, Tajiri N, Nakano M, et al. Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis. Mol Clin Oncol. 2014;2(3):393\u20138. https:\/\/doi.org\/10.3892\/mco.2014.259.","journal-title":"Mol Clin Oncol"},{"issue":"4","key":"5391_CR3","doi-asserted-by":"publisher","first-page":"e95889","DOI":"10.1371\/journal.pone.0095889","volume":"9","author":"F Xia","year":"2014","unstructured":"Xia F, Wu L, Lau WY, Li G, Huan H, Qian C, et al. Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis. PLoS ONE. 2014;9(4):e95889. https:\/\/doi.org\/10.1371\/journal.pone.0095889.","journal-title":"PLoS ONE"},{"key":"5391_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.gene.2018.07.001","volume":"676","author":"J Ma","year":"2018","unstructured":"Ma J, Zhang L, Yang P, Zeng ZC, Xiang ZL. Integrated analysis of long noncoding RNA expression profiles in lymph node metastasis of hepatocellular carcinoma. Gene. 2018;676:47\u201355. https:\/\/doi.org\/10.1016\/j.gene.2018.07.001.","journal-title":"Gene"},{"key":"5391_CR5","doi-asserted-by":"publisher","first-page":"1710670","DOI":"10.1155\/2019\/1710670","volume":"2019","author":"J Ma","year":"2019","unstructured":"Ma J, Zhang L, Bian HR, Lu ZG, Zhu L, Yang P, et al. A noninvasive prediction nomogram for lymph node metastasis of hepatocellular carcinoma based on serum long noncoding RNAs. Biomed Res Int. 2019;2019:1710670. https:\/\/doi.org\/10.1155\/2019\/1710670.","journal-title":"Biomed Res Int"},{"issue":"7629","key":"5391_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature20149","volume":"539","author":"JM Engreitz","year":"2016","unstructured":"Engreitz JM, Haines JE, Perez EM, Munson G, Chen J, Kane M, et al. Local regulation of gene expression by lncRNA promoters, transcription and splicing. Nature. 2016;539(7629):452\u20135. https:\/\/doi.org\/10.1038\/nature20149.","journal-title":"Nature"},{"issue":"3","key":"5391_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172(3):393\u2013407. https:\/\/doi.org\/10.1016\/j.cell.2018.01.011.","journal-title":"Cell"},{"key":"5391_CR8","doi-asserted-by":"publisher","first-page":"6571272","DOI":"10.1155\/2022\/6571272","volume":"2022","author":"Z Huang","year":"2022","unstructured":"Huang Z, He H, Qiu F, Qian H. Expression and prognosis value of the KLF family members in colorectal cancer. J Oncol. 2022;2022:6571272. https:\/\/doi.org\/10.1155\/2022\/6571272.","journal-title":"J Oncol"},{"issue":"2","key":"5391_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/jcp.1111","volume":"188","author":"AR Black","year":"2001","unstructured":"Black AR, Black JD, Azizkhan-Clifford J. Sp1 and Kr\u00fcppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol. 2001;188(2):143\u201360. https:\/\/doi.org\/10.1002\/jcp.1111.","journal-title":"J Cell Physiol"},{"issue":"15","key":"5391_CR10","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1073\/pnas.1613392114","volume":"114","author":"Y Manavski","year":"2017","unstructured":"Manavski Y, Abel T, Hu J, Kleinl\u00fctzum D, Buchholz CJ, Belz C, et al. Endothelial transcription factor KLF2 negatively regulates liver regeneration via induction of activin A. Proc Natl Acad Sci U S A. 2017;114(15):3993\u20138. https:\/\/doi.org\/10.1073\/pnas.1613392114.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5391_CR11","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1084\/jem.20031132","volume":"199","author":"S SenBanerjee","year":"2004","unstructured":"SenBanerjee S, Lin Z, Atkins GB, Greif DM, Rao RM, Kumar A, et al. KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med. 2004;199:1305\u201315.","journal-title":"J Exp Med"},{"key":"5391_CR12","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.3390\/ijms24054682","volume":"24","author":"VG Yerra","year":"2023","unstructured":"Yerra VG, Drosatos K. Specificity proteins (SP) and Kr\u00fcppel-like factors (KLF) in liver physiology and pathology. Int J Mol Sci. 2023;24:4682. https:\/\/doi.org\/10.3390\/ijms24054682.","journal-title":"Int J Mol Sci"},{"key":"5391_CR13","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/cas.13961","volume":"110","author":"J Lin","year":"2019","unstructured":"Lin J, Tan H, Nie Y, Wu D, Zheng W, Lin W, et al. Kr\u00fcppel-like factor 2 inhibits hepatocarcinogenesis through negative regulation of the hedgehog pathway. Cancer Sci. 2019;110:1220\u201331. https:\/\/doi.org\/10.1111\/cas.13961.","journal-title":"Cancer Sci"},{"issue":"45","key":"5391_CR14","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1038\/onc.2015.18","volume":"34","author":"TP Xu","year":"2015","unstructured":"Xu TP, Liu XX, Xia R, Yin L, Kong R, Chen WM, et al. SP1-induced upregulation of the long noncoding RNA TINCR regulates cell proliferation and apoptosis by affecting KLF2 mRNA stability in gastric cancer. Oncogene. 2015;34(45):5648\u201361. https:\/\/doi.org\/10.1038\/onc.2015.18.","journal-title":"Oncogene"},{"issue":"4","key":"5391_CR15","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1007\/s13277-014-2943-4","volume":"36","author":"L Yin","year":"2015","unstructured":"Yin L, Wang JP, Xu TP, Chen WM, Huang MD, Xia R, et al. Downregulation of Kruppel-like factor 2 is associated with poor prognosis for nonsmall-cell lung cancer. Tumour Biol J Int Soc Oncodev Biol Med. 2015;36(4):3075\u201384. https:\/\/doi.org\/10.1007\/s13277-014-2943-4.","journal-title":"Tumour Biol J Int Soc Oncodev Biol Med"},{"issue":"3","key":"5391_CR16","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1007\/s13277-015-4053-3","volume":"37","author":"D Zhang","year":"2016","unstructured":"Zhang D, Dai Y, Cai Y, Suo T, Liu H, Wang Y, et al. KLF2 is downregulated in pancreatic ductal adenocarcinoma and inhibits the growth and migration of cancer cells. Tumour Biol J Int Soc Oncodev Biol Med. 2016;37(3):3425\u201331. https:\/\/doi.org\/10.1007\/s13277-015-4053-3.","journal-title":"Tumour Biol J Int Soc Oncodev Biol Med."},{"issue":"1","key":"5391_CR17","doi-asserted-by":"publisher","first-page":"1817094795","DOI":"10.1177\/1557988318816907","volume":"13","author":"B Wang","year":"2019","unstructured":"Wang B, Liu M, Song Y, Li C, Zhang S, Ma L. KLF2 inhibits the migration and invasion of prostate cancer cells by downregulating mmp2. Am J Men\u2019s Health. 2019;13(1):1817094795. https:\/\/doi.org\/10.1177\/1557988318816907.","journal-title":"Am J Men's Health"},{"issue":"6","key":"5391_CR18","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1159\/000489589","volume":"46","author":"Z Ma","year":"2018","unstructured":"Ma Z, Peng P, Zhou J, Hui B, Ji H, Wang J, et al. Long non-coding RNA SH3PXD2A-AS1 promotes cell progression partly through epigenetic silencing P57 and KLF2 in colorectal cancer. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol. 2018;46(6):2197\u2013214. https:\/\/doi.org\/10.1159\/000489589.","journal-title":"Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol"},{"issue":"5","key":"5391_CR19","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.3892\/ijo.2018.4524","volume":"53","author":"E Xia","year":"2018","unstructured":"Xia E, Bhandari A, Shen Y, Zhou X, Wang O. lncRNA LINC00673 induces proliferation, metastasis and epithelial-mesenchymal transition in thyroid carcinoma via Kruppel-like factor 2. Int J Oncol. 2018;53(5):1927\u201338. https:\/\/doi.org\/10.3892\/ijo.2018.4524.","journal-title":"Int J Oncol"},{"key":"5391_CR20","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.omtn.2018.06.012","volume":"12","author":"Y Lian","year":"2018","unstructured":"Lian Y, Yan C, Xu H, Yang J, Yu Y, Zhou J, et al. A novel lncRNA, LINC00460, affects cell proliferation and apoptosis by regulating KLF2 and CUL4A expression in colorectal cancer. Mol Ther Nucleic Acids. 2018;12:684\u201397. https:\/\/doi.org\/10.1016\/j.omtn.2018.06.012.","journal-title":"Mol Ther Nucleic Acids"},{"key":"5391_CR21","doi-asserted-by":"publisher","first-page":"e105977","DOI":"10.15252\/embj.2020105977","volume":"40","author":"PC He","year":"2021","unstructured":"He PC, He C. m6A RNA methylation: from mechanisms to therapeutic potential. EMBO J. 2021;40:e105977. https:\/\/doi.org\/10.15252\/embj.2020105977.","journal-title":"EMBO J"},{"key":"5391_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-1109-9","volume":"18","author":"L He","year":"2019","unstructured":"He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of n6-methyladenosine and its role in cancer. Mol Cancer. 2019;18:1\u201315. https:\/\/doi.org\/10.1186\/s12943-019-1109-9.","journal-title":"Mol Cancer"},{"issue":"1","key":"5391_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-019-1066-3","volume":"18","author":"Y Li","year":"2019","unstructured":"Li Y, Xiao J, Bai J, Tian Y, Qu Y, Chen X, et al. Molecular characterization and clinical relevance of m6A regulators across 33 cancer types. Mol Cancer. 2019;18(1):137. https:\/\/doi.org\/10.1186\/s12943-019-1066-3.","journal-title":"Mol Cancer"},{"key":"5391_CR24","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28:1947\u201351. https:\/\/doi.org\/10.1002\/pro.3715.","journal-title":"Protein Sci"},{"key":"5391_CR25","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1152\/physrev.00058.2009","volume":"90","author":"BB McConnell","year":"2010","unstructured":"McConnell BB, Yang VW. Mammalian Kr\u00fcppel-like factors in health and diseases. Physiol Rev. 2010;90:1337\u201381. https:\/\/doi.org\/10.1152\/physrev.00058.2009.","journal-title":"Physiol Rev"},{"key":"5391_CR26","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1053\/j.gastro.2017.03.035","volume":"152","author":"C Kim","year":"2017","unstructured":"Kim C, He P, Bialkowska AB, Yang VW. SP and KLF transcription factors in digestive physiology and diseases. Gastroenterology. 2017;152:1845\u201375. https:\/\/doi.org\/10.1053\/j.gastro.2017.03.035.","journal-title":"Gastroenterology"},{"key":"5391_CR27","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.1111\/bph.14838","volume":"177","author":"R Wang","year":"2020","unstructured":"Wang R, Geller DA, Wink DA, Cheng B, Billiar TR. No and hepatocellular cancer. Br J Pharmacol. 2020;177:5459\u201366. https:\/\/doi.org\/10.1111\/bph.14838.","journal-title":"Br J Pharmacol"},{"key":"5391_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12916-022-02523-w","volume":"20","author":"T Chen","year":"2022","unstructured":"Chen T, Shi Z, Zhao Y, Meng X, Zhao S, Zheng L, et al. LncRNA Airn maintains LSEC differentiation to alleviate liver fibrosis via the KLF2-eNOS-sGC pathway. BMC Med. 2022;20:335. https:\/\/doi.org\/10.1186\/s12916-022-02523-w.","journal-title":"BMC Med"},{"issue":"1","key":"5391_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-019-1906-x","volume":"21","author":"E Madissoon","year":"2019","unstructured":"Madissoon E, Wilbrey-Clark A, Miragaia RJ, Saeb-Parsy K, Mahbubani KT, Georgakopoulos N, et al. scRNA-seq assessment of the human lung, spleen, and esophagus tissue stability after cold preservation. Genome Biol. 2019;21(1):1. https:\/\/doi.org\/10.1186\/s13059-019-1906-x.","journal-title":"Genome Biol"},{"issue":"1","key":"5391_CR30","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1038\/s41467-018-06318-7","volume":"9","author":"SA MacParland","year":"2018","unstructured":"MacParland SA, Liu JC, Ma XZ, Innes BT, Bartczak AM, Gage BK, et al. Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nat Commun. 2018;9(1):4383. https:\/\/doi.org\/10.1038\/s41467-018-06318-7.","journal-title":"Nat Commun"},{"issue":"2","key":"5391_CR31","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cmet.2019.05.007","volume":"30","author":"R Ouchi","year":"2019","unstructured":"Ouchi R, Togo S, Kimura M, Shinozawa T, Koido M, Koike H, et al. Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids. Cell Metab. 2019;30(2):374\u201384. https:\/\/doi.org\/10.1016\/j.cmet.2019.05.007.","journal-title":"Cell Metab"},{"key":"5391_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrc.2017.118","volume":"18","author":"T Brabletz","year":"2018","unstructured":"Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nat Rev Cancer. 2018;18:128\u201334. https:\/\/doi.org\/10.1038\/nrc.2017.118.","journal-title":"Nat Rev Cancer"},{"key":"5391_CR33","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.jhep.2016.05.007","volume":"65","author":"G Giannelli","year":"2016","unstructured":"Giannelli G, Koudelkova P, Dituri F, Mikulits W. Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J Hepatol. 2016;65:798\u2013808. https:\/\/doi.org\/10.1016\/j.jhep.2016.05.007.","journal-title":"J Hepatol"},{"issue":"9","key":"5391_CR34","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582\u201398. https:\/\/doi.org\/10.1038\/nrc.2016.73.","journal-title":"Nat Rev Cancer"},{"key":"5391_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-pathol-052016-100322","volume":"12","author":"S Affo","year":"2017","unstructured":"Affo S, Yu LX, Schwabe RF. The role of cancer-associated fibroblasts and fibrosis in liver cancer. Annu Rev Pathol. 2017;12:153\u201386. https:\/\/doi.org\/10.1146\/annurev-pathol-052016-100322.","journal-title":"Annu Rev Pathol"},{"key":"5391_CR36","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.2147\/CMAR.S176152","volume":"10","author":"B Zou","year":"2018","unstructured":"Zou B, Liu X, Gong Y, Cai C, Li P, Xing S, et al. A novel 12-marker panel of cancer-associated fibroblasts involved in progression of hepatocellular carcinoma. Cancer Manag Res. 2018;10:5303\u201311. https:\/\/doi.org\/10.2147\/CMAR.S176152.","journal-title":"Cancer Manag Res"},{"key":"5391_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071723","author":"J Baglieri","year":"2019","unstructured":"Baglieri J, Brenner DA, Kisseleva T. The role of fibrosis and liver-associated fibroblasts in the pathogenesis of hepatocellular carcinoma. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20071723.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"5391_CR38","first-page":"4060","volume":"7","author":"NS Fedarko","year":"2001","unstructured":"Fedarko NS, Jain A, Karadag A, Van Eman MR, Fisher LW. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2001;7(12):4060\u20136.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"4","key":"5391_CR39","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.ajo.2006.11.040","volume":"143","author":"IW Reiniger","year":"2007","unstructured":"Reiniger IW, Wolf A, Welge-L\u00fcssen U, Mueller AJ, Kampik A, Schaller UC. Osteopontin as a serologic marker for metastatic uveal melanoma: results of a pilot study. Am J Ophthalmol. 2007;143(4):705\u20137. https:\/\/doi.org\/10.1016\/j.ajo.2006.11.040.","journal-title":"Am J Ophthalmol"},{"key":"5391_CR40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41421-020-0157-z","volume":"6","author":"J Zhao","year":"2020","unstructured":"Zhao J, Zhang S, Liu Y, He X, Qu M, Xu G, et al. Single-cell RNA sequencing reveals the heterogeneity of liver-resident immune cells in human. Cell Discov. 2020;6:22. https:\/\/doi.org\/10.1038\/s41421-020-0157-z.","journal-title":"Cell Discov"},{"key":"5391_CR41","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","volume":"27","author":"JE Smith-Garvin","year":"2009","unstructured":"Smith-Garvin JE, Koretzky GA, Jordan MS. T cell activation. Annu Rev Immunol. 2009;27:591\u2013619. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132706.","journal-title":"Annu Rev Immunol"},{"key":"5391_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-017-0513-0","volume":"10","author":"M Huang","year":"2017","unstructured":"Huang M, Chen W, Qi F, Xia R, Sun M, Xu T, et al. Erratum to: long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell proliferation by epigenetic silencing of KLF2. J Hematol Oncol. 2017;10:1\u20131. https:\/\/doi.org\/10.1186\/s13045-017-0513-0.","journal-title":"J Hematol Oncol"},{"key":"5391_CR43","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/gut.2010.220913","volume":"60","author":"J Gracia-Sancho","year":"2011","unstructured":"Gracia-Sancho J, Russo L, Garc\u00eda-Calder\u00f3 H, Garc\u00eda-Pag\u00e1n JC, Garc\u00eda-Carde\u00f1a G, Bosch J. Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver. Gut. 2011;60:517\u201324. https:\/\/doi.org\/10.1136\/gut.2010.220913.","journal-title":"Gut"},{"key":"5391_CR44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jhep.2012.08.026","volume":"58","author":"G Marrone","year":"2013","unstructured":"Marrone G, Russo L, Rosado E, Hide D, Garc\u00eda-Carde\u00f1a G, Garc\u00eda-Pag\u00e1n JC, et al. The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins. J Hepatol. 2013;58:98\u2013103. https:\/\/doi.org\/10.1016\/j.jhep.2012.08.026.","journal-title":"J Hepatol"},{"key":"5391_CR45","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Investig. 2005;115:209\u201318.","journal-title":"J Clin Investig"},{"key":"5391_CR46","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/abbs\/gmaa024","volume":"52","author":"Y Li","year":"2020","unstructured":"Li Y, Tu S, Zeng Y, Zhang C, Deng T, Luo W, et al. KLF2 inhibits TGF-\u03b2-mediated cancer cell motility in hepatocellular carcinoma. Acta Biochim Biophys Sin. 2020;52:485\u201394. https:\/\/doi.org\/10.1093\/abbs\/gmaa024.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"9","key":"5391_CR47","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1016\/j.ajpath.2015.05.019","volume":"185","author":"WC Chen","year":"2015","unstructured":"Chen WC, Lin HH, Tang MJ. Matrix-stiffness-regulated inverse expression of Kr\u00fcppel-like factor 5 and Kr\u00fcppel-like factor 4 in the pathogenesis of renal fibrosis. Am J Pathol. 2015;185(9):2468\u201381. https:\/\/doi.org\/10.1016\/j.ajpath.2015.05.019.","journal-title":"Am J Pathol"},{"issue":"13","key":"5391_CR48","doi-asserted-by":"publisher","first-page":"11661","DOI":"10.1074\/jbc.M211337200","volume":"278","author":"KE King","year":"2003","unstructured":"King KE, Iyemere VP, Weissberg PL, Shanahan CM. Kr\u00fcppel-like factor 4 (KLF4\/GKLF) is a target of bone morphogenetic proteins and transforming growth factor beta 1 in the regulation of vascular smooth muscle cell phenotype. J Biol Chem. 2003;278(13):11661\u20139. https:\/\/doi.org\/10.1074\/jbc.M211337200.","journal-title":"J Biol Chem"},{"issue":"5","key":"5391_CR49","doi-asserted-by":"publisher","first-page":"F1388","DOI":"10.1152\/ajprenal.00055.2008","volume":"295","author":"J Holian","year":"2008","unstructured":"Holian J, Qi W, Kelly DJ, Zhang Y, Mreich E, Pollock CA, et al. Role of Kruppel-like factor 6 in transforming growth factor-beta1-induced epithelial-mesenchymal transition of proximal tubule cells. Am J Physiol Renal Physiol. 2008;295(5):F1388\u201396. https:\/\/doi.org\/10.1152\/ajprenal.00055.2008.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"5391_CR50","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1159\/000355743","volume":"37","author":"X Gao","year":"2013","unstructured":"Gao X, Wu G, Gu X, Fu L, Mei C. Kruppel-like factor 15 modulates renal interstitial fibrosis by ERK\/MAPK and JNK\/MAPK pathways regulation. Kidney Blood Press Res. 2013;37(6):631\u201340. https:\/\/doi.org\/10.1159\/000355743.","journal-title":"Kidney Blood Press Res"},{"issue":"19","key":"5391_CR51","doi-asserted-by":"publisher","first-page":"8887","DOI":"10.1158\/0008-5472.CAN-05-1702","volume":"65","author":"F Yang","year":"2005","unstructured":"Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, Rowley DR. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res. 2005;65(19):8887\u201395. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-1702.","journal-title":"Cancer Res"},{"issue":"3","key":"5391_CR52","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated sdf-1\/cxcl12 secretion. Cell. 2005;121(3):335\u201348. https:\/\/doi.org\/10.1016\/j.cell.2005.02.034.","journal-title":"Cell"},{"key":"5391_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clinbiochem.2018.07.003","volume":"59","author":"MA Icer","year":"2018","unstructured":"Icer MA, Gezmen-Karadag M. The multiple functions and mechanisms of osteopontin. Clin Biochem. 2018;59:17\u201324. https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.07.003.","journal-title":"Clin Biochem"},{"issue":"4","key":"5391_CR54","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nm843","volume":"9","author":"QH Ye","year":"2003","unstructured":"Ye QH, Qin LX, Forgues M, He P, Kim JW, Peng AC, et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med. 2003;9(4):416\u201323. https:\/\/doi.org\/10.1038\/nm843.","journal-title":"Nat Med"},{"issue":"11","key":"5391_CR55","first-page":"6924","volume":"11","author":"J Wang","year":"2019","unstructured":"Wang J, Hao F, Fei X, Chen Y. SPP1 functions as an enhancer of cell growth in hepatocellular carcinoma targeted by mir-181c. Am J Transl Res. 2019;11(11):6924\u201337.","journal-title":"Am J Transl Res"},{"issue":"5334","key":"5391_CR56","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1126\/science.277.5334.1986","volume":"277","author":"CT Kuo","year":"1997","unstructured":"Kuo CT, Veselits ML, Leiden JM. LKLF: a transcriptional regulator of single-positive t cell quiescence and survival. Science (New York, NY). 1997;277(5334):1986\u201390. https:\/\/doi.org\/10.1126\/science.277.5334.1986.","journal-title":"Science (New York, N.Y.)"},{"issue":"49","key":"5391_CR57","doi-asserted-by":"publisher","first-page":"8088","DOI":"10.1038\/sj.onc.1207996","volume":"23","author":"J Wu","year":"2004","unstructured":"Wu J, Lingrel JB. KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1\/CIP1. Oncogene. 2004;23(49):8088\u201396. https:\/\/doi.org\/10.1038\/sj.onc.1207996.","journal-title":"Oncogene"},{"issue":"8","key":"5391_CR58","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/90633","volume":"2","author":"AF Buckley","year":"2001","unstructured":"Buckley AF, Kuo CT, Leiden JM. Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway. Nat Immunol. 2001;2(8):698\u2013704. https:\/\/doi.org\/10.1038\/90633.","journal-title":"Nat Immunol"},{"key":"5391_CR59","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20202898","author":"Z Zhu","year":"2021","unstructured":"Zhu Z, Ye W, Wu X, Lin S, Xu J, Li L, et al. Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironment. 2021. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20202898."},{"issue":"1","key":"5391_CR60","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2217\/imt-2019-0145","volume":"12","author":"Y Yang","year":"2020","unstructured":"Yang Y, Zang Y, Zheng C, Li Z, Gu X, Zhou M, et al. CD3D is associated with immune checkpoints and predicts favorable clinical outcome in colon cancer. Immunotherapy. 2020;12(1):25\u201335. https:\/\/doi.org\/10.2217\/imt-2019-0145.","journal-title":"Immunotherapy"},{"key":"5391_CR61","doi-asserted-by":"publisher","first-page":"215867","DOI":"10.1016\/j.canlet.2022.215867","volume":"547","author":"Y Hu","year":"2022","unstructured":"Hu Y, Lu Y, Xing F, Hsu W. FGFR1\/MAPK-directed brachyury activation drives PD-L1-mediated immune evasion to promote lung cancer progression. Cancer Lett. 2022;547:215867. https:\/\/doi.org\/10.1016\/j.canlet.2022.215867.","journal-title":"Cancer Lett"}],"updated-by":[{"DOI":"10.1186\/s12859-023-05623-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000}}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-023-05391-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-023-05391-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-023-05391-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T11:02:33Z","timestamp":1704279753000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-023-05391-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5391"],"URL":"https:\/\/doi.org\/10.1186\/s12859-023-05391-0","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}],"correction":[{"id-type":"doi","id":"10.1186\/s12859-023-05623-3","asserted-by":"object"}]},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"4 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12859-023-05623-3","URL":"https:\/\/doi.org\/10.1186\/s12859-023-05623-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The public database used in this study is available for public access and re-analysis without requiring ethical approval from the local ethics committees. Therefore, this study does not require ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest in this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"270"}}